![Committee chairman Rep. Jason Smith (R-MO) speaks with ranking member Rep. Richard Neal (D-MA) during a House Ways and Means Committee hearing on Capitol Hill March 10, 2023 in Washington, DC. – health care policy coverage from STAT](https://www.statnews.com/wp-content/uploads/2023/07/GettyImages-1247992295-645x645.jpg)
WASHINGTON — It’s two weeks until Congress leaves town in August, and a prominent House panel is throwing a wrench in what seemed like a smooth path forward for legislation to require more transparency in health care prices, and to change Medicare drug payments.
The House Energy & Commerce Committee already introduced, held multiple hearings on, and unanimously passed out of committee a package of legislation including transparency requirements for hospitals and pharmacy benefit managers and a so-called “site-neutral” pay policy for drugs administered in doctors’ offices.
But leaders of the House Ways & Means Committee are planning to release their own health care legislation this month, complicating the chamber’s path to passing something soon, four lobbyists told STAT.
Exciting news! STAT has moved its comment section to our subscriber-only app, STAT+ Connect. Subscribe to STAT+ today to join the conversation or join us on Twitter, Facebook, LinkedIn, and Threads. Let's stay connected!
To submit a correction request, please visit our Contact Us page.